Biomarin Pharmaceutical Inc. (BMRN) announced a profit for its fourth quarter that rose from the same period last year.
The company's bottom line came in at $22.10 million, or $0.12 per share. This compares with $15.02 million, or $0.08 per share, in last year's fourth quarter.
Analysts had expected the company to earn -$0.19 per share, according to figures compiled by Thomson Reuters. Analysts' estimates typically exclude special items.
The company's revenue for the quarter fell 0.5% to $452.12 million from $454.44 million last year.
Biomarin Pharmaceutical Inc. earnings at a glance:
-Earnings (Q4): $22.10 Mln. vs. $15.02 Mln. last year.
-EPS (Q4): $0.12 vs. $0.08 last year.
-Analysts Estimate: -$0.19
-Revenue (Q4): $452.12 Mln vs. $454.44 Mln last year.
For comments and feedback: editorial@rttnews.com